Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:25 PM
Ignite Modification Date:
2025-12-24 @ 12:25 PM
NCT ID:
NCT07277361
Eligibility Criteria:
Inclusion Criteria:
* Men and women aged 65 and over with a diagnosis of Fabry disease with, for men, a proven alpha-galactosidase A deficiency or an identified pathogenic GLA genetic variant, and for women, an identified pathogenic GLA variant.
* Minimum work-up available: ECG, 24h holterECG, cardiac ultrasound, creatinemia, proteinuria and/or microalbuminuria.
* Have received written and oral information about the protocol and have not expressed any opposition to participating in the study.
* Affiliated to a social security scheme or entitled to benefits (excluding AME).
Exclusion Criteria:
* Inability to understand the information provided,
* Under guardianship, curatorship or safeguard of justice,
* Under restraint or deprived of liberty by judicial or administrative decision.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT07277361
Study Brief:
Protocol Section:
NCT07277361